Understanding the barriers and facilitators of vaccine hesitancy towards the COVID-19 vaccine in healthcare workers and healthcare students worldwide: An Umbrella Review.


Journal

PloS one
ISSN: 1932-6203
Titre abrégé: PLoS One
Pays: United States
ID NLM: 101285081

Informations de publication

Date de publication:
2023
Historique:
received: 27 10 2022
accepted: 31 12 2022
medline: 14 4 2023
entrez: 12 4 2023
pubmed: 13 4 2023
Statut: epublish

Résumé

Healthcare workers (HCWs) and healthcare students display high levels of vaccine hesitancy with impact on healthcare provision, patient safety, and health promotion. The factors related to vaccine hesitancy have been reported in several systematic reviews. However, this evidence needs to be synthesised, as interventions to reduce vaccination hesitancy in this population are needed. This Umbrella Review aimed to explore the barriers and facilitators of vaccine hesitancy toward the COVID-19 vaccine for HCWs and healthcare students. The review was performed and reported in accordance with Joanna Briggs Institutes guidelines and the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. A protocol was preregistered on PROSPERO (CRD42022327354). Eight databases were searched from November 2019 to 23rd May 2022 to identify any systematic reviews that explored factors associated with hesitancy towards the COVID-19 vaccine for HCWs or healthcare students. A total of 31 studies were included in the review. The majority of studies (71%) were appraised as strong or moderate quality and there was a slight degree of overlap (<5%) of primary studies between the reviews. Vaccine hesitancy was more common among HCWs and healthcare students in specific occupational roles (e.g. nurses) than others (e.g. physicians). Frequent reasons for hesitancy were related to sociodemographic factors (gender, age, ethnicity), occupational factors (COVID-19 exposure, perceived risk, mandatory vaccination), health factors (vaccination history), vaccine-related factors (concerns about safety, efficacy, side-effects, rapid development, testing, approval and distribution of the vaccine), social factors (social pressure, altruism and collective responsibility), distrust factors (key social actors, pandemic management), information factors (inadequate information and sources, exposure to misinformation). The results from this Umbrella Review have wide-reaching implications for the research area, healthcare systems and institutions and governments worldwide. Designing tailored strategies for specific occupational groups is pivotal to increasing vaccine uptake and securing a safe healthcare provision worldwide.

Sections du résumé

BACKGROUND
Healthcare workers (HCWs) and healthcare students display high levels of vaccine hesitancy with impact on healthcare provision, patient safety, and health promotion. The factors related to vaccine hesitancy have been reported in several systematic reviews. However, this evidence needs to be synthesised, as interventions to reduce vaccination hesitancy in this population are needed.
METHODS
This Umbrella Review aimed to explore the barriers and facilitators of vaccine hesitancy toward the COVID-19 vaccine for HCWs and healthcare students. The review was performed and reported in accordance with Joanna Briggs Institutes guidelines and the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines. A protocol was preregistered on PROSPERO (CRD42022327354). Eight databases were searched from November 2019 to 23rd May 2022 to identify any systematic reviews that explored factors associated with hesitancy towards the COVID-19 vaccine for HCWs or healthcare students.
RESULTS
A total of 31 studies were included in the review. The majority of studies (71%) were appraised as strong or moderate quality and there was a slight degree of overlap (<5%) of primary studies between the reviews. Vaccine hesitancy was more common among HCWs and healthcare students in specific occupational roles (e.g. nurses) than others (e.g. physicians). Frequent reasons for hesitancy were related to sociodemographic factors (gender, age, ethnicity), occupational factors (COVID-19 exposure, perceived risk, mandatory vaccination), health factors (vaccination history), vaccine-related factors (concerns about safety, efficacy, side-effects, rapid development, testing, approval and distribution of the vaccine), social factors (social pressure, altruism and collective responsibility), distrust factors (key social actors, pandemic management), information factors (inadequate information and sources, exposure to misinformation).
CONCLUSION
The results from this Umbrella Review have wide-reaching implications for the research area, healthcare systems and institutions and governments worldwide. Designing tailored strategies for specific occupational groups is pivotal to increasing vaccine uptake and securing a safe healthcare provision worldwide.

Identifiants

pubmed: 37043505
doi: 10.1371/journal.pone.0280439
pii: PONE-D-22-29425
pmc: PMC10096263
doi:

Substances chimiques

COVID-19 Vaccines 0

Types de publication

Journal Article Review Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0280439

Informations de copyright

Copyright: © 2023 McCready et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Déclaration de conflit d'intérêts

The authors have declared that no competing interests exist.

Références

Postgrad Med J. 2023 Jun 15;99(1172):520-528
pubmed: 37319159
Anaesth Crit Care Pain Med. 2021 Jun;40(3):100860
pubmed: 33848874
Br J Health Psychol. 2020 Nov;25(4):981-1005
pubmed: 32780891
Vaccines (Basel). 2020 Dec 30;9(1):
pubmed: 33396832
Science. 2021 Mar 26;371(6536):1289
pubmed: 33766861
Vaccines (Basel). 2022 Jan 12;10(1):
pubmed: 35062771
J Am Geriatr Soc. 2021 May;69(5):1140-1146
pubmed: 33764497
Infect Prev Pract. 2020 Sep;2(3):100073
pubmed: 34316562
Vaccine. 2020 Sep 29;38(42):6500-6507
pubmed: 32863069
Glob Health Res Policy. 2022 Jul 19;7(1):21
pubmed: 35850783
Public Health. 2022 Jun;207:94-104
pubmed: 35594808
Vaccines (Basel). 2021 Aug 06;9(8):
pubmed: 34452000
Vaccines (Basel). 2021 Feb 03;9(2):
pubmed: 33546165
J Clin Nurs. 2022 Jan;31(1-2):62-86
pubmed: 34227179
BMJ. 2021 Mar 29;372:n71
pubmed: 33782057
Emerg Infect Dis. 2021 Sep;27(9):2454-2458
pubmed: 34193339
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
PLoS One. 2022 May 11;17(5):e0267691
pubmed: 35544545
J Clin Epidemiol. 2016 Jul;75:40-6
pubmed: 27005575
Int J Environ Res Public Health. 2022 Mar 29;19(7):
pubmed: 35409755
Int J Evid Based Healthc. 2015 Sep;13(3):132-40
pubmed: 26360830
N Engl J Med. 2022 Jul 7;387(1):58-65
pubmed: 35767527
Front Public Health. 2021 Aug 13;9:698111
pubmed: 34485229
J Med Libr Assoc. 2016 Jul;104(3):240-3
pubmed: 27366130
MMWR Morb Mortal Wkly Rep. 2021 Aug 13;70(32):1081-1083
pubmed: 34383732
Am J Infect Control. 2021 Oct;49(10):1295-1304
pubmed: 34273461
J Community Health. 2021 Dec;46(6):1244-1251
pubmed: 33877534
BMJ Glob Health. 2021 Sep;6(9):
pubmed: 34593513
Infect Drug Resist. 2021 Sep 21;14:3883-3897
pubmed: 34584432
Vaccines (Basel). 2022 Feb 02;10(2):
pubmed: 35214687
Br J Psychol. 2021 Aug;112(3):763-780
pubmed: 33474747
Front Public Health. 2021 Sep 28;9:747787
pubmed: 34650953
J Adolesc Health. 2020 Aug;67(2):179-185
pubmed: 32487491
Risk Manag Healthc Policy. 2021 Jun 21;14:2609-2623
pubmed: 34188572
Bratisl Lek Listy. 2021;122(8):538-547
pubmed: 34282618
J Public Health Afr. 2022 May 24;13(1):2181
pubmed: 35720806
Vaccines (Basel). 2022 Mar 11;10(3):
pubmed: 35335059
Hum Vaccin Immunother. 2022 Nov 30;18(5):2043719
pubmed: 35318872
Prev Med Rep. 2021 Dec 16;25:101673
pubmed: 34934611
Int J Environ Res Public Health. 2021 Sep 04;18(17):
pubmed: 34501932
J Adv Nurs. 2022 Sep;78(9):2894-2903
pubmed: 35301774
BMJ. 2021 May 20;373:n1138
pubmed: 34016653
New Bioeth. 2022 Mar;28(1):27-39
pubmed: 35049419
BMC Infect Dis. 2022 Jun 1;22(1):511
pubmed: 35650539
Vaccines (Basel). 2021 Nov 19;9(11):
pubmed: 34835289
Syst Rev. 2016 Dec 5;5(1):210
pubmed: 27919275
Soc Sci Med. 2020 Nov;265:113501
pubmed: 33203551
J Clin Epidemiol. 2014 Apr;67(4):368-75
pubmed: 24581293
Public Health. 2021 May;194:245-251
pubmed: 33965796
Hum Vaccin Immunother. 2022 Nov 30;18(5):2054260
pubmed: 35438612
Clin Infect Dis. 2021 Sep 15;73(6):e1337-e1344
pubmed: 33851216
Brain Behav Immun Health. 2021 Oct;16:100289
pubmed: 34226892
Vaccines (Basel). 2021 May 08;9(5):
pubmed: 34066790
Front Public Health. 2021 Nov 23;9:770985
pubmed: 34888288
PLoS One. 2020 Jul 9;15(7):e0234827
pubmed: 32645112
Psychol Health. 2013;28(5):579-92
pubmed: 23259583
PLoS One. 2022 Apr 19;17(4):e0267354
pubmed: 35439274

Auteurs

Jemma Louise McCready (JL)

Department of Social Work, Education and Community Wellbeing, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, United Kingdom.

Bethany Nichol (B)

Department of Social Work, Education and Community Wellbeing, Northumbria University, Newcastle upon Tyne, United Kingdom.

Mary Steen (M)

Department of Nursing, Midwifery and Health, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, United Kingdom.

John Unsworth (J)

Department of Nursing, Midwifery and Health, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, United Kingdom.

Dania Comparcini (D)

Politecnica delle Marche University of Ancona, Ancona, Italy.

Marco Tomietto (M)

Department of Nursing, Midwifery and Health, Faculty of Health and Life Sciences, Northumbria University, Newcastle upon Tyne, United Kingdom.
Research Unit of Nursing Science and Health Management, University of Oulu, Oulu, Finland.
University of Bari "Aldo Moro", Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH